Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2013.10.005 ◽

2013 ◽

Vol 102 (3) ◽

pp. 233-241 ◽

Author(s):

Heather M. Campbell ◽

Nasreen Khan ◽

Dennis W. Raisch ◽

Matthew E. Borrego ◽

Mike R. Sather ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Disease Mortality ◽

Receptor Blockers ◽

Stage Renal Disease ◽

Download Full-text

Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis

Kidney International ◽

10.1038/ki.2015.96 ◽

2015 ◽

Vol 88 (2) ◽

pp. 378-385 ◽

Author(s):

Ting-Tse Lin ◽

Yao-Hsu Yang ◽

Min-Tsun Liao ◽

Chia-Ti Tsai ◽

Juey J. Hwang ◽

...

Keyword(s):

End Stage Renal Disease ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Stage Renal Disease ◽

Download Full-text

End-stage renal disease and adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes

Journal of Clinical Hypertension ◽

10.1111/jch.12976 ◽

2017 ◽

Vol 19 (6) ◽

pp. 627-631 ◽

Author(s):

Michal Shani ◽

Shlomo Vinker ◽

Leonid Feldman

Keyword(s):

End Stage Renal Disease ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Patients With Diabetes ◽

Receptor Blockers ◽

Stage Renal Disease ◽

Download Full-text

Faculty Opinions recommendation of Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725403752.793505721 ◽

2015 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

End Stage Renal Disease ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers ◽

Stage Renal Disease ◽

Download Full-text

End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study

Internal Medicine Journal ◽

10.1111/imj.13971 ◽

2018 ◽

Vol 48 (9) ◽

pp. 1123-1132

Author(s):

Hsin-Fu Lee ◽

Lai-Chu See ◽

Yi-Hsin Chan ◽

Yung-Hsin Yeh ◽

Lung-Sheng Wu ◽

...

Keyword(s):

End Stage Renal Disease ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Risk Of Mortality ◽

Receptor Blockers ◽

Stage Renal Disease ◽

Download Full-text

Response to the Letter to the Editor From Dr Kawada, “Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus”

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.004 ◽

2020 ◽

Vol 44 (1) ◽

pp. 5

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Hypertensive Patients ◽

Receptor Blockers

Download Full-text

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Diabetic Medicine ◽

10.1111/dme.14107 ◽

2019 ◽

Vol 37 (1) ◽

pp. 44-52 ◽

Author(s):

C. I. Coleman ◽

E. R. Weeda ◽

A. Kharat ◽

B. Bookhart ◽

W. L. Baker

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

PDB12 Comparative Effectiveness Study of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Type 2 Diabetes

Value in Health ◽

10.1016/j.jval.2012.03.933 ◽

2012 ◽

Vol 15 (4) ◽

pp. A172

Author(s):

H.M. Campbell ◽

N. Khan ◽

D.W. Raisch ◽

M. Borrego ◽

M. Sather ◽

...

Keyword(s):

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Effectiveness Study ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Comparative Effectiveness Study ◽

Receptor Blockers

Download Full-text

Effect of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers on the Prevention of Death in Patients with Type 2 Diabetes and Undetermined Nephropathy : Five-Year Survival Data

Journal of Diabetes & Metabolism ◽

10.4172/2155-6156.1000188 ◽

2012 ◽

Vol 03 (04) ◽

Author(s):

Sirima Mongkolsomlit ◽

Petch Rawdaree ◽

Chulalux Komoltri

Keyword(s):

Type 2 Diabetes ◽

Survival Data ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes

Current Hypertension Reports ◽

10.1007/s11906-002-0005-6 ◽

2002 ◽

Vol 4 (3) ◽

pp. 185-190 ◽

Author(s):

Jay Garg ◽

George L. Bakris

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.01.001 ◽

2020 ◽

Vol 44 (1) ◽

pp. 4 ◽

Author(s):

Tomoyuki Kawada

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Angiotensin Receptor Blockers ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitors ◽

Hypertensive Patients ◽

Receptor Blockers

Download Full-text